Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myelomaPatrick J Stiff, Ivana Micallef, Auayporn P Nademanee, et al.
Blood|December 4, 2008
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Bruno Nervi, Pablo Ramirez, Michael P Rettig, et al.
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Blood|April 14, 2009
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F DiPersio, Edward A Stadtmauer, Auayporn Nademanee, et al.
The Journal of Experimental Medicine|April 20, 2005
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonistHal E Broxmeyer, Christie M Orschell, D Wade Clapp, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replicationRenato Skerlj, Gary Bridger, Ernest McEachern, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2010
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replicationRenato Skerlj, Gary Bridger, Ernie McEachern, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 4